This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research on the Frontline #3

Research on the Frontline #3

Liverpool University Hospital's Lead Research Nurse, Deborah Scanlon, talks about her role has changed due to the current COVID-19 pandemic and why she believes the world can now have a better understanding of the importance of research in medicine.


Full name and role: Deborah Scanlon Lead Infectious Diseases Research Nurse

Department currently working on: Infectious Diseases, Liverpool University Hospitals NHS Foundation Trust

Research trials you’re involved in: HIV trials, pneumonia trails, brain infections and many Covid-19 trials


Please give us an outline of how you’re finding working during COVID-19:

All my other studies are on hold to allow maximum recruitment to the Covid-19 trials.

All of the other research teams have experienced the same, and we are working as one in order to understand what this virus is doing to patients.

It feels good to know that there is a massive concerted effort across research to try to combat this disease.

I feel proud to be playing a very active role in the Covid-19 trials.

I set up the ISARIC CCP study here at Liverpool Foundation Trust back in January this year and we were able to recruit the first positive Covid 19 patient admitted to the Trust in February.

Since then we have almost 600 people in the study. We have collected data and samples from the patients. The data and samples will help in the on-going effort to try to beat this virus that has cost so many lives

Why do you think research is important?

I think the Covid-19 trials have shown the world the importance of research in medicine.


A huge thank you to Deborah Scanlon, Lead Research Nurse in the Infectious Diseases Department at The Royal Liverpool site, Liverpool University Hospital NHS Foundation Trust.